Medico Remedies Limited (MEDICO.BO)
INR 51.69
(3.44%)
INR 51.69
(3.44%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 262.14 Million INR | 1.72% |
| 2022 | 257.7 Million INR | 13.92% |
| 2021 | 226.22 Million INR | 8.45% |
| 2020 | 208.6 Million INR | 36.16% |
| 2019 | 153.2 Million INR | 20.94% |
| 2018 | 126.67 Million INR | -1.57% |
| 2017 | 128.69 Million INR | -4.48% |
| 2016 | 134.74 Million INR | -1.53% |
| 2015 | 136.83 Million INR | 16.39% |
| 2014 | 117.57 Million INR | 13.88% |
| 2013 | 103.24 Million INR | 66.16% |
| 2012 | 62.13 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 65.48 Million INR | -25.85% |
| 2023 Q3 | 82.17 Million INR | -0.71% |
| 2023 Q4 | 88.31 Million INR | 7.47% |
| 2023 FY | 262.14 Million INR | 1.72% |
| 2023 Q1 | 75.88 Million INR | 461.15% |
| 2023 Q2 | 82.75 Million INR | 9.06% |
| 2022 Q4 | -21.01 Million INR | -119.95% |
| 2022 Q3 | 105.32 Million INR | -0.23% |
| 2022 Q2 | 105.57 Million INR | 55.67% |
| 2022 Q1 | 67.81 Million INR | 535.99% |
| 2022 FY | 257.7 Million INR | 13.92% |
| 2021 Q4 | -15.55 Million INR | -116.63% |
| 2021 Q1 | 51.1 Million INR | -15.64% |
| 2021 Q2 | 97.24 Million INR | 90.3% |
| 2021 Q3 | 93.51 Million INR | -3.84% |
| 2021 FY | 226.22 Million INR | 8.45% |
| 2020 Q2 | 84.07 Million INR | 0.0% |
| 2020 Q4 | 60.57 Million INR | 0.0% |
| 2020 Q3 | 60.57 Million INR | -27.96% |
| 2020 Q1 | 84.07 Million INR | 65.97% |
| 2020 FY | 208.6 Million INR | 36.16% |
| 2019 Q3 | 50.65 Million INR | -0.21% |
| 2019 Q1 | 50.76 Million INR | 4.22% |
| 2019 FY | 153.2 Million INR | 20.94% |
| 2019 Q4 | 50.65 Million INR | 0.0% |
| 2019 Q2 | 50.76 Million INR | 0.0% |
| 2018 Q4 | 48.7 Million INR | 0.0% |
| 2018 FY | 126.67 Million INR | -1.57% |
| 2018 Q3 | 48.7 Million INR | 23.94% |
| 2018 Q1 | 39.3 Million INR | -7.35% |
| 2018 Q2 | 39.3 Million INR | 0.0% |
| 2017 FY | 128.69 Million INR | -4.48% |
| 2017 Q1 | 41.88 Million INR | 0.0% |
| 2017 Q2 | 41.88 Million INR | 0.0% |
| 2017 Q3 | 42.42 Million INR | 1.28% |
| 2017 Q4 | 42.42 Million INR | 0.0% |
| 2016 FY | 134.74 Million INR | -1.53% |
| 2015 FY | 136.83 Million INR | 16.39% |
| 2014 FY | 117.57 Million INR | 13.88% |
| 2013 FY | 103.24 Million INR | 66.16% |
| 2012 FY | 62.13 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Ajanta Pharma Limited | 21.06 Billion INR | 98.755% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | 83.158% |
| Sigachi Industries Limited | 2 Billion INR | 86.908% |
| Bal Pharma Limited | 770.19 Million INR | 65.964% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | 95.768% |
| Lasa Supergenerics Limited | 121.02 Million INR | -116.594% |
| Venus Remedies Limited | 2.18 Billion INR | 87.989% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 143.516% |
| Alpa Laboratories Limited | 188.89 Million INR | -38.778% |
| Nectar Lifesciences Limited | 2.97 Billion INR | 91.18% |
| Shilpa Medicare Limited | 3.54 Billion INR | 92.609% |
| Aarti Drugs Limited | 8.31 Billion INR | 96.848% |
| Lupin Limited | 123.71 Billion INR | 99.788% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 99.831% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 99.791% |
| Windlas Biotech Limited | 1.33 Billion INR | 80.419% |
| Suven Life Sciences Limited | -200.79 Million INR | 230.552% |
| Eris Lifesciences Limited | 10.42 Billion INR | 97.486% |
| Valiant Laboratories Limited | -60.66 Million INR | 532.124% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | 98.845% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | 69.561% |
| Ipca Laboratories Limited | 29.8 Billion INR | 99.121% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | 92.906% |
| Achyut Healthcare Limited | 4.86 Million INR | -5292.8% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 99.899% |
| Bajaj HealthCare Limited | 1.47 Billion INR | 82.189% |
| RPG Life Sciences Limited | 2.48 Billion INR | 89.442% |
| Mankind Pharma Limited | 44.52 Billion INR | 99.411% |
| Laurus Labs Limited | 24.62 Billion INR | 98.935% |
| Piramal Pharma Limited | 24.47 Billion INR | 98.929% |
| Syncom Formulations (India) Limited | 942.39 Million INR | 72.183% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 99.439% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 99.021% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 99.622% |
| Unichem Laboratories Limited | 4.86 Billion INR | 94.612% |
| Sequent Scientific Limited | 2.97 Billion INR | 91.199% |
| Novartis India Limited | 1.32 Billion INR | 80.244% |
| Wanbury Limited | 1.73 Billion INR | 84.853% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | 93.642% |
| Wockhardt Limited | 16.24 Billion INR | 98.386% |
| Themis Medicare Limited | 1.5 Billion INR | 82.569% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | 59.83% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 98.665% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 97.892% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 99.84% |
| Divi's Laboratories Limited | 32.44 Billion INR | 99.192% |
| NATCO Pharma Limited | 25.73 Billion INR | 98.981% |
| Gufic Biosciences Limited | 4.16 Billion INR | 93.71% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | 94.277% |
| Ind-Swift Limited | 2.17 Billion INR | 87.934% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 95.466% |
| FDC Limited | 8.33 Billion INR | 96.855% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -36.018% |
| Granules India Limited | 16.79 Billion INR | 98.44% |
| Medicamen Biotech Limited | 495.49 Million INR | 47.095% |
| Alkem Laboratories Limited | 52.29 Billion INR | 99.499% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 95.787% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -1698.007% |
| Brooks Laboratories Limited | 65.62 Million INR | -299.488% |
| Megasoft Limited | 342.07 Million INR | 23.366% |
| ZIM Laboratories Limited | 1.26 Billion INR | 79.308% |
| Strides Pharma Science Limited | 14.38 Billion INR | 98.178% |
| Neuland Laboratories Limited | 8.24 Billion INR | 96.822% |
| Morepen Laboratories Limited | 6.16 Billion INR | 95.745% |
| Hikal Limited | 3.14 Billion INR | 91.66% |
| Indoco Remedies Limited | 6.04 Billion INR | 95.661% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 95.505% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | 57.751% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | 62.743% |
| Hester Biosciences Limited | 1.27 Billion INR | 79.418% |